EU Approves Roche's Actemra/RoActemra Against Severe Covid-19 - MarketWatch

Retrieved on: 2021-12-07 10:54:53

Tags for this article:

Click the tags to see associated articles and topics

EU Approves Roche's Actemra/RoActemra Against Severe Covid-19 - MarketWatch. View article details on hiswai:

Excerpt

By Mauro Orru The European Union approved a potential medicine developed by Roche Holding AG to treat people with severe Covid-19.

Article found on: www.marketwatch.com